InvestorsHub Logo
Followers 0
Posts 20
Boards Moderated 0
Alias Born 07/16/2006

Re: None

Thursday, 01/10/2019 11:03:24 AM

Thursday, January 10, 2019 11:03:24 AM

Post# of 34625
erg61...Any reasonable thoughts as to why the s/p is where it’s at?

Here's my thoughts (hopefully reasonable). After investing in several biotechs over many years, I am convinced that algorithmic based computer programs, or market makers, or big pocket players control individual stock prices on most days in most early stage biotechs. The typical pattern after good news is released is that the stock makes a huge jump. There are no investors selling who are in the stock for the long term. The selling comes from the entities previously mentioned. They then wait for the inevitable low volume down day to drive the price down, and keep it down until their short sales are repurchased. These entities make money on volatility, not when stocks sit still. Early stage biotechs have no earnings, dividends or other impetus to keep the stock price somewhat stable. True value is only recognized when another company makes a bid for MRKR or MRKR starts sales. Even this is no guaranty. There have been periods in stock market history where stocks sold for less than their book value. The only investing method that works is to buy cheaply and hang on for dear life. Like Buffet said, "Buy when there is blood in the streets."
One poster mentioned that there isn't much likelihood of news in the 1st qtr. This is a prescription for a slowly declining stock price in this type of stock. GLTA. Looking to buy in the near future.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MRKR News